|
EP2251341A1
(en)
*
|
2005-07-14 |
2010-11-17 |
Astellas Pharma Inc. |
Heterocyclic Janus kinase 3 inhibitors
|
|
WO2007007919A2
(en)
|
2005-07-14 |
2007-01-18 |
Astellas Pharma Inc. |
Heterocyclic janus kinase 3 inhibitors
|
|
EP2455382B1
(en)
|
2005-12-13 |
2016-10-26 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
JPWO2008053652A1
(ja)
|
2006-11-02 |
2010-02-25 |
塩野義製薬株式会社 |
ヒドロキシアダマンタンアミンの製造方法
|
|
EP2123651A4
(en)
*
|
2007-01-12 |
2011-05-04 |
Astellas Pharma Inc |
CONDENSED PYRIDINE COMPOUND
|
|
EP3070090B1
(en)
|
2007-06-13 |
2018-12-12 |
Incyte Holdings Corporation |
Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile
|
|
US8541426B2
(en)
|
2007-07-11 |
2013-09-24 |
Pfizer Inc. |
Pharmaceutical compositions and methods of treating dry eye disorders
|
|
CA2703477C
(en)
*
|
2007-10-25 |
2016-10-11 |
Exelixis, Inc. |
Pyridinyl substituted tropane compounds and uses thereof
|
|
JP5748659B2
(ja)
*
|
2008-06-10 |
2015-07-15 |
アッヴィ・インコーポレイテッド |
新規な三環式化合物
|
|
CL2009001884A1
(es)
*
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
DE102008052943A1
(de)
|
2008-10-23 |
2010-04-29 |
Merck Patent Gmbh |
Azaindolderivate
|
|
JPWO2010058846A1
(ja)
*
|
2008-11-21 |
2012-04-19 |
アステラス製薬株式会社 |
４，６−ジアミノニコチンアミド化合物
|
|
WO2010061971A1
(ja)
*
|
2008-11-28 |
2010-06-03 |
興和株式会社 |
ピリジン－３－カルボキシアミド誘導体
|
|
SG176111A1
(en)
|
2009-05-22 |
2011-12-29 |
Incyte Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
JP5775070B2
(ja)
|
2009-05-22 |
2015-09-09 |
インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ |
ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体
|
|
ES2540964T3
(es)
|
2009-06-08 |
2015-07-15 |
Takeda Pharmaceutical Company Limited |
Compuestos de dihidropirrolonaftiridinona como inhibidores de JAK
|
|
US9346809B2
(en)
|
2009-07-08 |
2016-05-24 |
Leo Pharma A/S |
Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors
|
|
FR2948369B1
(fr)
|
2009-07-27 |
2013-04-12 |
Sanofi Aventis |
Derives d'uree de tetrahydroquinoxaline, leur preparation et leur application en therapeutique
|
|
FR2948370B1
(fr)
|
2009-07-27 |
2013-04-05 |
Sanofi Aventis |
Derives d'uree de tetrahydroquinoxaline, leur preparation et leur application en therapeutique
|
|
AR078012A1
(es)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
|
|
CA2776028C
(en)
|
2009-10-15 |
2015-12-01 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidine compounds
|
|
PE20121336A1
(es)
*
|
2009-12-01 |
2012-11-03 |
Abbvie Inc |
Nuevos compuestos triciclicos
|
|
KR20120102724A
(ko)
*
|
2009-12-01 |
2012-09-18 |
아보트 러보러터리즈 |
신규한 트리사이클릭 화합물
|
|
ES2461967T3
(es)
|
2009-12-18 |
2014-05-21 |
Pfizer Inc. |
Compuestos de pirrolo[2,3-d]pirimidina
|
|
EP2523957A1
(en)
*
|
2010-01-12 |
2012-11-21 |
F. Hoffmann-La Roche AG |
Tricyclic heterocyclic compounds, compositions and methods of use thereof
|
|
PT3354652T
(pt)
|
2010-03-10 |
2020-07-20 |
Incyte Holdings Corp |
Derivados de piperidin-4-ilazetidina como inibidores de jak1
|
|
US8518945B2
(en)
|
2010-03-22 |
2013-08-27 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
|
CN102906095A
(zh)
|
2010-05-20 |
2013-01-30 |
弗·哈夫曼-拉罗切有限公司 |
作为syk和jak抑制剂的吡咯并吡嗪衍生物
|
|
RS54824B1
(sr)
|
2010-05-21 |
2016-10-31 |
Incyte Holdings Corp |
Topikalna formulacija za inhibiciju jak-a
|
|
EP2592080B1
(en)
*
|
2010-06-23 |
2016-02-24 |
Astellas Pharma Inc. |
Crystal of fused pyridine compound salt
|
|
US9198911B2
(en)
|
2010-11-02 |
2015-12-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating hair loss disorders
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
BR112013017184A2
(pt)
*
|
2011-01-07 |
2016-09-20 |
Leo Pharma As |
composto, composição farmacêutica, uso de um composto, e, método para evitar, tratar ou melhorar doenças
|
|
CA2827673C
(en)
|
2011-02-18 |
2020-10-27 |
Novartis Pharma Ag |
Mtor/jak inhibitor combination therapy
|
|
WO2012127506A1
(en)
|
2011-03-22 |
2012-09-27 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
EP2741747A1
(en)
|
2011-08-10 |
2014-06-18 |
Novartis Pharma AG |
JAK P13K/mTOR COMBINATION THERAPY
|
|
AU2012295802B2
(en)
|
2011-08-12 |
2017-03-30 |
Nissan Chemical Industries, Ltd. |
Tricyclic heterocyclic compounds and JAK inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
KR102032934B1
(ko)
*
|
2011-12-21 |
2019-10-16 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
|
|
ES2567552T3
(es)
*
|
2012-01-30 |
2016-04-25 |
Cephalon, Inc. |
Imidazo [4,5-b] derivados de piridina como los moduladores ALK y JAK para el tratamiento de trastornos proliferativos
|
|
WO2013117649A1
(en)
*
|
2012-02-10 |
2013-08-15 |
Galapagos Nv |
Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
|
|
UY34616A
(es)
*
|
2012-02-10 |
2013-09-30 |
Galapagos Nv |
Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
|
|
JP6123795B2
(ja)
*
|
2012-03-30 |
2017-05-10 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
GB201211021D0
(en)
*
|
2012-06-21 |
2012-08-01 |
Cancer Rec Tech Ltd |
Pharmaceutically active compounds
|
|
EP2895172B1
(en)
|
2012-09-12 |
2019-02-06 |
Rigel Pharmaceuticals, Inc. |
Treatment for vitiligo
|
|
IN2015DN02008A
(https=)
|
2012-09-21 |
2015-08-14 |
Advinus Therapeutics Ltd |
|
|
CN113384546A
(zh)
|
2012-11-15 |
2021-09-14 |
因赛特公司 |
鲁索利替尼的缓释剂型
|
|
TW201513861A
(zh)
*
|
2013-01-17 |
2015-04-16 |
Galapagos Nv |
用於治療退化性及發炎疾病之新穎化合物
|
|
JP6248948B2
(ja)
|
2013-02-08 |
2017-12-20 |
日産化学工業株式会社 |
３環性ピロロピリジン化合物及びｊａｋ阻害剤
|
|
WO2014138168A1
(en)
|
2013-03-06 |
2014-09-12 |
Incyte Corporation |
Processes and intermediates for making a jak inhibitor
|
|
WO2014146246A1
(en)
*
|
2013-03-19 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
|
|
WO2014157603A1
(ja)
|
2013-03-29 |
2014-10-02 |
アステラス製薬株式会社 |
経口投与用医薬組成物
|
|
SG10201801069QA
(en)
|
2013-08-07 |
2018-03-28 |
Incyte Corp |
Sustained release dosage forms for a jak1 inhibitor
|
|
KR101548492B1
(ko)
|
2013-09-23 |
2015-09-01 |
건국대학교 산학협력단 |
야누스 키나아제 1 (Janus kinase 1)의 활성을 선택적으로 저해하는 4-아미노-7-아자인돌-5-카르복사마이드 유도체
|
|
MX368464B
(es)
|
2013-12-05 |
2019-10-02 |
Pfizer |
Acrilamidas de pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinil o y pirrolo[2,3-d]piridinilo.
|
|
ES2745156T3
(es)
*
|
2014-04-22 |
2020-02-27 |
Arqule Inc |
Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido
|
|
WO2015174376A1
(ja)
|
2014-05-14 |
2015-11-19 |
日産化学工業株式会社 |
３環性化合物及びｊａｋ阻害剤
|
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
|
WO2016047678A1
(ja)
*
|
2014-09-25 |
2016-03-31 |
武田薬品工業株式会社 |
複素環化合物
|
|
AR105392A1
(es)
*
|
2015-07-20 |
2017-09-27 |
Genzyme Corp |
Inhibidores del receptor del factor estimulador de colonias 1 (csf-1r)
|
|
US11365198B2
(en)
|
2015-10-16 |
2022-06-21 |
Abbvie Inc. |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
|
|
US11780848B2
(en)
|
2015-10-16 |
2023-10-10 |
Abbvie Inc. |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof
|
|
EP3362455A1
(en)
|
2015-10-16 |
2018-08-22 |
AbbVie Inc. |
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
|
|
US12365689B2
(en)
|
2015-10-16 |
2025-07-22 |
Abbvie Inc. |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
|
|
US10550126B2
(en)
|
2015-10-16 |
2020-02-04 |
Abbvie Inc. |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
|
|
US11512092B2
(en)
|
2015-10-16 |
2022-11-29 |
Abbvie Inc. |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
|
|
US11524964B2
(en)
|
2015-10-16 |
2022-12-13 |
Abbvie Inc. |
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
|
|
US10730871B2
(en)
*
|
2016-01-28 |
2020-08-04 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
EP3481826B1
(en)
|
2016-07-08 |
2021-11-03 |
Rigel Pharmaceuticals, Inc. |
Tyrosine kinase inhibitors
|
|
LT3555097T
(lt)
*
|
2016-12-16 |
2022-08-25 |
Janssen Pharmaceutica Nv |
Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai
|
|
JOP20190144A1
(ar)
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
|
JP2018104412A
(ja)
*
|
2016-12-22 |
2018-07-05 |
参天製薬株式会社 |
眼疾患の治療及び／又は予防剤
|
|
EP3562809B1
(en)
|
2016-12-29 |
2021-06-09 |
F. Hoffmann-La Roche AG |
Pyrazolopyrimidine compounds and methods of use thereof
|
|
KR101896568B1
(ko)
|
2017-03-23 |
2018-09-10 |
재단법인 대구경북첨단의료산업진흥재단 |
피롤로-피리딘 유도체 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
WO2019057103A1
(zh)
*
|
2017-09-21 |
2019-03-28 |
上海华汇拓医药科技有限公司 |
Jak激酶抑制剂及其制备方法和在医药领域的应用
|
|
GB201717260D0
(en)
*
|
2017-10-20 |
2017-12-06 |
Galapagos Nv |
Novel compounds and pharma ceutical compositions thereof for the treatment of inflammatory disorders
|
|
EP3710431A4
(en)
*
|
2017-11-03 |
2021-07-07 |
Aclaris Therapeutics, Inc. |
SUBSTITUTED PYRROLOPYRIMIDINE-BASED JAK INHIBITORS AND THEIR MANUFACTURING AND USE PROCEDURES
|
|
US10800775B2
(en)
|
2017-11-03 |
2020-10-13 |
Aclaris Therapeutics, Inc. |
Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
|
|
AR113922A1
(es)
|
2017-12-08 |
2020-07-01 |
Incyte Corp |
Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
|
|
EA202091830A1
(ru)
|
2018-01-30 |
2020-12-29 |
Инсайт Корпорейшн |
Способы и промежуточные соединения для получения ингибитора jak
|
|
MD3773593T2
(ro)
|
2018-03-30 |
2024-10-31 |
Incyte Corp |
Tratament hidradenitei supurative utilizând inhibitori ai JAK
|
|
TW202016110A
(zh)
|
2018-06-15 |
2020-05-01 |
比利時商健生藥品公司 |
Ｊａｋ激酶家族之小分子抑制劑
|
|
WO2020009946A1
(en)
|
2018-07-02 |
2020-01-09 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods of use thereof
|
|
WO2020033955A1
(en)
|
2018-08-10 |
2020-02-13 |
Aclaris Therapeutics, Inc. |
Pyrrolopyrimidine itk inhibitors
|
|
US12275731B2
(en)
|
2018-10-16 |
2025-04-15 |
Dana-Farber Cancer Institute, Inc. |
Azaindole inhibitors of wild-type and mutant forms of LRRK2
|
|
US12240844B2
(en)
|
2019-01-18 |
2025-03-04 |
Voronoi, Inc. |
Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease
|
|
KR102737181B1
(ko)
*
|
2019-03-14 |
2024-12-02 |
상하이 시너지 파마슈티컬 사이언시스 코., 엘티디. |
Jak 억제제 및 그 제조방법과 의약분야에서의 응용
|
|
WO2020223728A1
(en)
|
2019-05-02 |
2020-11-05 |
Aclaris Therapeutics, Inc. |
Substituted pyrrolopyridines as jak inhibitors
|
|
KR102286372B1
(ko)
*
|
2019-05-27 |
2021-08-05 |
주식회사한국파마 |
Jak 저해제 화합물, 및 이를 포함하는 의약 조성물
|
|
CN112174951A
(zh)
*
|
2019-07-02 |
2021-01-05 |
深圳美莹基因科技有限公司 |
作为詹纳斯激酶1选择抑制剂的吡咯并[2，3-b]吡啶衍生物
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
WO2021257857A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Naphthyridinone compounds as jak2 v617f inhibitors
|
|
WO2021257863A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Pyrrolotriazine compounds as jak2 v617f inhibitors
|
|
SMT202500271T1
(it)
|
2020-07-02 |
2025-09-12 |
Incyte Corp |
Composti di urea triciclici come inibitori di v617f di jak2
|
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
|
US11661422B2
(en)
|
2020-08-27 |
2023-05-30 |
Incyte Corporation |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
KR102551758B1
(ko)
*
|
2020-11-30 |
2023-07-05 |
주식회사한국파마 |
신규한 jak 특이 저해제 화합물, 및 이의 제조방법
|
|
KR20220081631A
(ko)
|
2020-12-09 |
2022-06-16 |
보로노이 주식회사 |
염증성 질환의 예방 및/또는 치료를 위한 피롤로-피리딘 유도체 화합물의 신규 용도
|
|
WO2022140231A1
(en)
|
2020-12-21 |
2022-06-30 |
Incyte Corporation |
Deazaguaine compounds as jak2 v617f inhibitors
|
|
AR125273A1
(es)
|
2021-02-25 |
2023-07-05 |
Incyte Corp |
Lactamas espirocíclicas como inhibidores de jak2 v617f
|
|
BR112023018286A2
(pt)
|
2021-03-11 |
2023-10-31 |
Janssen Pharmaceutica Nv |
Lorpucitinib para uso no tratamento de distúrbios mediados por jak
|
|
CN119173514A
(zh)
|
2022-03-17 |
2024-12-20 |
因赛特公司 |
作为jak2 v617f抑制剂的三环脲化合物
|
|
JP2025516222A
(ja)
*
|
2022-04-28 |
2025-05-27 |
杭州普済遠成生物医薬科技有限公司 |
脱ユビキチン化酵素阻害剤及びその応用
|
|
CN116283963A
(zh)
*
|
2022-12-05 |
2023-06-23 |
西安美莹基因科技有限公司 |
一种高效詹纳斯激酶1选择性抑制剂
|